Prove safety and effectiveness as well as improvement in near visual acuity performance and increase in near visual acuity. 3 months [clinicaltrials_resource:a278e7f4c10a19231c9f0de5218112b3]

Prove safety and effectiveness as well as improvement in near visual acuity performance and increase in near visual acuity. 3 months [clinicaltrials_resource:a278e7f4c10a19231c9f0de5218112b3]

Presbyopic patients, slightly hyperopes
clinicaltrials resource [clinicaltrials_vocabulary:Resource]
Secondary outcome [clinicaltrials_vocabulary:secondary-outcome]
http://bio2rdf.org/clinicaltrials_resource:a278e7f4c10a19231c9f0de5218112b3
Intrastromal Correction of Ametropia by a Femtosecond Laser [clinicaltrials:NCT00928122]
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]

Prove safety and effectiveness as well as improvement in near visual acuity performance and increase in near visual acuity. 3 months [clinicaltrials_resource:a278e7f4c10a19231c9f0de5218112b3]

Presbyopic patients, slightly hyperopes
clinicaltrials resource [clinicaltrials_vocabulary:Resource]
Secondary outcome [clinicaltrials_vocabulary:secondary-outcome]
http://bio2rdf.org/clinicaltrials_resource:a278e7f4c10a19231c9f0de5218112b3
Bio2RDF identifier
a278e7f4c10a19231c9f0de5218112b3
Bio2RDF namespace
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:a278e7f4c10a19231c9f0de5218112b3
measure [clinicaltrials_vocabulary:measure]
Prove safety and effectiveness ...... ncrease in near visual acuity.
time frame [clinicaltrials_vocabulary:time-frame]
description
Presbyopic patients, slightly hyperopes
identifier
clinicaltrials_resource:a278e7f4c10a19231c9f0de5218112b3
title
Prove safety and effectiveness ...... n near visual acuity. 3 months
@en
inDataset
type
label
Prove safety and effectiveness ...... 8e7f4c10a19231c9f0de5218112b3]
@en